Merck Animal Health Acquires TARGAN to Advance Poultry Technology
RAHWAY, N.J., June 11, 2026 Merck Animal Health, a division of Merck & Co., Inc., has signed a definitive...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
RAHWAY, N.J., June 11, 2026 Merck Animal Health, a division of Merck & Co., Inc., has signed a definitive...
TUCSON, Arizona, USA, June 11, 2026 Roche Diagnostics has announced a significant expansion of its precision oncology diagnostics portfolio...
LUND, Sweden, June 8, 2026 Alligator Bioscience announced a significant development in the ongoing global Phase 3 clinical trial...
SANTA CLARA, Calif., June 2, 2026 Agilent Technologies announced that the U.S. Food and Drug Administration (FDA) has approved...
OSAKA, Japan, June 2, 2026 Ono Pharmaceutical announced positive Phase 2 clinical trial results for ONO-4578, its investigational oral...
SHANGHAI, China, June 1, 2026 CARsgen Therapeutics presented promising long-term follow-up data from its investigational Claudin18.2-targeted CAR T-cell therapy,...
SUZHOU, China, May 29, 2026 Suzhou Ribo Life Science and Ribocure Pharmaceuticals (collectively “Ribo”) have announced the submission of...
SHANGHAI and HONG KONG, China, May 28, 2026 Antengene has announced a major clinical development milestone after receiving endorsement...
TAIPEI, Taiwan, SHANGHAI, China and SAN FRANCISCO, California — May 28, 2026 HanchorBio, Inc. announced that the company will...
TOKYO, JAPAN, March 23, 2026 Daiichi Sankyo has announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved...
